Just as an example.
Herceptin is a massive selling drug (now off patent, so there's the generic sales too). $10b plus per year.
But in gastric cancer it achieves only a 12% increase in median overall survival (that's only an extra 1.4 months). But yet it's worth a fortune in sales!
http://www.herceptin.com/gastric
- Forums
- ASX - By Stock
- PTX
- Ann: Encouraging data from PTX-200 ovarian cancer trial
Ann: Encouraging data from PTX-200 ovarian cancer trial, page-40
-
-
- There are more pages in this discussion • 132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.3¢ |
Change
0.001(2.38%) |
Mkt cap ! $33.82M |
Open | High | Low | Value | Volume |
4.2¢ | 4.3¢ | 4.2¢ | $880 | 20.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 95108 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 225514 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 95108 | 0.042 |
3 | 1034391 | 0.041 |
8 | 697493 | 0.040 |
5 | 389000 | 0.039 |
2 | 225000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 225514 | 2 |
0.045 | 831675 | 6 |
0.047 | 525000 | 2 |
0.048 | 58027 | 1 |
0.050 | 310539 | 3 |
Last trade - 10.52am 19/08/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |